A clinical trial to study the effect of Unani drugs in patient with worm infestation

An open labelled randomized controlled clinical trial to evaluate safety and efficacy of qurse deedane jadeed in case of deedane tiwal [ascaris lumbricoides] - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075828

Enrollment

Registered

2024-10-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B770- Ascariasis with intestinal complications

Interventions

Intervention1: UNANI DRUG - Qurse-Deedane Jadeed: Twenty patients are treated with the Unani formulation Qurse-Deedane Jadeed for 14 days to assess efficacy. Dossage details: (1 Tab - 775 mg), 2 - T

Eligibility

Inclusion criteria

Inclusion criteria: 1. History of Passing an Adult Worm. 2. Patient Complaining of Abdominal Pain, Fever, Nausea/Vomiting Increase and decrease in Appetite. 3. Allergic Manifestation, Itching, Urticaria. 4. Both Gender 5. Age between 14 – 45 years

Exclusion criteria

Exclusion criteria: 1. Severe Abdominal Pain, Severe Growth Retardation, Severe Anemia. 2. Major Medical Illness. 3. Patient with Severe Jaundice. 4. Peritonitis. 5. Evidence of Perforation. 6. Pregnant & Lactating Women

Design outcomes

Primary

Measure	Time frame
Cure the worm infestationTimepoint: Once in a week	—

Secondary

Measure	Time frame
To relieve Abdominal Pain, Growth Retardation and Severe AnemiaTimepoint: Once in a week	—

Countries

India

Contacts

Public ContactDrN Narsimha

Govt. Nizamia Tibbi College and General Hospital, Charminar, Hyderabad.

dr.n.narasimha@gmail.com9866985269

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026